Titre : Acquisition d'organes et de tissus

Acquisition d'organes et de tissus : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Acquisition d'organes et de tissus : Questions médicales les plus fréquentes", "headline": "Acquisition d'organes et de tissus : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Acquisition d'organes et de tissus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-25", "dateModified": "2025-04-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Acquisition d'organes et de tissus" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Services de santé", "url": "https://questionsmedicales.fr/mesh/D006296", "about": { "@type": "MedicalCondition", "name": "Services de santé", "code": { "@type": "MedicalCode", "code": "D006296", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.421" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Banque du sang", "alternateName": "Blood Banking", "url": "https://questionsmedicales.fr/mesh/D000094902", "about": { "@type": "MedicalCondition", "name": "Banque du sang", "code": { "@type": "MedicalCode", "code": "D000094902", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.421.911.050" } } }, { "@type": "MedicalWebPage", "name": "Don du sang", "alternateName": "Blood Donation", "url": "https://questionsmedicales.fr/mesh/D000094345", "about": { "@type": "MedicalCondition", "name": "Don du sang", "code": { "@type": "MedicalCode", "code": "D000094345", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.421.911.100" } } }, { "@type": "MedicalWebPage", "name": "Don dirigé de tissus", "alternateName": "Directed Tissue Donation", "url": "https://questionsmedicales.fr/mesh/D033001", "about": { "@type": "MedicalCondition", "name": "Don dirigé de tissus", "code": { "@type": "MedicalCode", "code": "D033001", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.421.911.200" } } }, { "@type": "MedicalWebPage", "name": "Sélection de donneurs", "alternateName": "Donor Selection", "url": "https://questionsmedicales.fr/mesh/D046148", "about": { "@type": "MedicalCondition", "name": "Sélection de donneurs", "code": { "@type": "MedicalCode", "code": "D046148", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.421.911.600" } } } ], "about": { "@type": "MedicalCondition", "name": "Acquisition d'organes et de tissus", "alternateName": "Tissue and Organ Procurement", "code": { "@type": "MedicalCode", "code": "D009927", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sumit Mohan", "url": "https://questionsmedicales.fr/author/Sumit%20Mohan", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, New York, USA." } }, { "@type": "Person", "name": "Joel T Adler", "url": "https://questionsmedicales.fr/author/Joel%20T%20Adler", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Division of Transplant Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA." } }, { "@type": "Person", "name": "Brianna Doby", "url": "https://questionsmedicales.fr/author/Brianna%20Doby", "affiliation": { "@type": "Organization", "name": "Department of Public Health Sciences, New Mexico State University, College of Health, Education, and Social Transformation, Las Cruces." } }, { "@type": "Person", "name": "Jon J Snyder", "url": "https://questionsmedicales.fr/author/Jon%20J%20Snyder", "affiliation": { "@type": "Organization", "name": "Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA; Department of Medicine, Hennepin Healthcare, University of Minnesota, Minneapolis, Minnesota, USA; Department of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA. Electronic address: Jon.Snyder@cdrg.org." } }, { "@type": "Person", "name": "Daniel J Lebovitz", "url": "https://questionsmedicales.fr/author/Daniel%20J%20Lebovitz", "affiliation": { "@type": "Organization", "name": "Pediatric Critical Care, Akron Childrens' Hospital, Akron, Ohio." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Videoconference-Delivered Cognitive Behavioral Therapy for Parents of Adolescents With Internet Addiction: Pilot Randomized Controlled Trial.", "datePublished": "2024-10-03", "url": "https://questionsmedicales.fr/article/39361415", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/60604" } }, { "@type": "ScholarlyArticle", "name": "The Statistical Fragility of Outcomes on Breast Reconstruction with Acellular Dermal Matrix: A Systematic Review of Randomized Controlled Trials.", "datePublished": "2024-10-01", "url": "https://questionsmedicales.fr/article/39356685", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/PRS.0000000000011798" } }, { "@type": "ScholarlyArticle", "name": "Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial.", "datePublished": "2024-09-30", "url": "https://questionsmedicales.fr/article/39349629", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41591-024-03263-5" } }, { "@type": "ScholarlyArticle", "name": "Efficiency assessment of intelligent patient-specific instrumentation in total knee arthroplasty: a prospective randomized controlled trial.", "datePublished": "2024-09-28", "url": "https://questionsmedicales.fr/article/39342311", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13018-024-05010-5" } }, { "@type": "ScholarlyArticle", "name": "Local and non-local effects (on the posterior chain) of four weeks of foot exercises: a randomized controlled trial.", "datePublished": "2024-09-23", "url": "https://questionsmedicales.fr/article/39317709", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-71585-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Établissements, main d'oeuvre et services de soins de santé", "item": "https://questionsmedicales.fr/mesh/D005159" }, { "@type": "ListItem", "position": 3, "name": "Services de santé", "item": "https://questionsmedicales.fr/mesh/D006296" }, { "@type": "ListItem", "position": 4, "name": "Acquisition d'organes et de tissus", "item": "https://questionsmedicales.fr/mesh/D009927" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Acquisition d'organes et de tissus - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Acquisition d'organes et de tissus", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Acquisition d'organes et de tissus", "description": "Comment évaluer la nécessité d'une transplantation ?\nQuels tests sont utilisés pour le don d'organes ?\nComment déterminer la compatibilité des donneurs ?\nQuels critères excluent un donneur potentiel ?\nComment évaluer la fonction d'un organe avant le don ?", "url": "https://questionsmedicales.fr/mesh/D009927?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=999#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Acquisition d'organes et de tissus", "description": "Quels signes indiquent un besoin d'organe ?\nComment reconnaître une réaction au rejet ?\nQuels symptômes d'infection post-transplantation ?\nQuels signes d'une mauvaise fonction rénale ?\nComment identifier une complication pulmonaire ?", "url": "https://questionsmedicales.fr/mesh/D009927?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=999#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Acquisition d'organes et de tissus", "description": "Comment promouvoir le don d'organes ?\nQuelles sont les mesures de sécurité pour les donneurs ?\nComment éviter les infections chez les receveurs ?\nQuelles sont les recommandations pour les receveurs ?\nComment sensibiliser à l'importance du don ?", "url": "https://questionsmedicales.fr/mesh/D009927?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=999#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Acquisition d'organes et de tissus", "description": "Quels traitements sont nécessaires après une transplantation ?\nComment prévenir le rejet d'organe ?\nQuels sont les traitements pour les complications ?\nComment gérer les effets secondaires des médicaments ?\nQuels sont les traitements pour les infections post-transplantation ?", "url": "https://questionsmedicales.fr/mesh/D009927?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=999#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Acquisition d'organes et de tissus", "description": "Quelles sont les complications possibles après une transplantation ?\nComment gérer le rejet aigu ?\nQuels sont les signes d'une infection grave ?\nQuelles complications cardiovasculaires peuvent survenir ?\nComment prévenir les complications à long terme ?", "url": "https://questionsmedicales.fr/mesh/D009927?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=999#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Acquisition d'organes et de tissus", "description": "Quels facteurs augmentent le besoin de transplantation ?\nComment l'âge influence-t-il le don d'organes ?\nQuels comportements augmentent les risques de maladies ?\nComment les antécédents familiaux influencent-ils le risque ?\nQuels facteurs socio-économiques influencent le don ?", "url": "https://questionsmedicales.fr/mesh/D009927?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=999#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la nécessité d'une transplantation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation inclut des tests médicaux, des antécédents et des examens physiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le don d'organes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins, d'imagerie et de compatibilité tissulaire sont effectués." } }, { "@type": "Question", "name": "Comment déterminer la compatibilité des donneurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La compatibilité est évaluée par des tests HLA et des groupes sanguins." } }, { "@type": "Question", "name": "Quels critères excluent un donneur potentiel ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies infectieuses, des cancers ou des antécédents médicaux graves peuvent exclure." } }, { "@type": "Question", "name": "Comment évaluer la fonction d'un organe avant le don ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction hépatique, rénale ou cardiaque sont réalisés pour évaluer l'organe." } }, { "@type": "Question", "name": "Quels signes indiquent un besoin d'organe ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue extrême, douleurs, défaillance d'organe et symptômes d'insuffisance." } }, { "@type": "Question", "name": "Comment reconnaître une réaction au rejet ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes incluent fièvre, douleur, gonflement et dysfonction de l'organe transplanté." } }, { "@type": "Question", "name": "Quels symptômes d'infection post-transplantation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, rougeur et douleur au site de la transplantation sont fréquents." } }, { "@type": "Question", "name": "Quels signes d'une mauvaise fonction rénale ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oligurie, œdème, hypertension et fatigue peuvent indiquer une défaillance rénale." } }, { "@type": "Question", "name": "Comment identifier une complication pulmonaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Toux persistante, essoufflement et douleur thoracique peuvent signaler une complication." } }, { "@type": "Question", "name": "Comment promouvoir le don d'organes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Sensibilisation, éducation et campagnes d'information encouragent le don d'organes." } }, { "@type": "Question", "name": "Quelles sont les mesures de sécurité pour les donneurs ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des évaluations médicales rigoureuses et des protocoles de sécurité sont mis en place." } }, { "@type": "Question", "name": "Comment éviter les infections chez les receveurs ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Hygiène rigoureuse, vaccinations et suivi médical régulier aident à prévenir les infections." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les receveurs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Suivre les prescriptions, éviter les infections et assister aux rendez-vous médicaux." } }, { "@type": "Question", "name": "Comment sensibiliser à l'importance du don ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes médiatiques et des témoignages de receveurs peuvent sensibiliser le public." } }, { "@type": "Question", "name": "Quels traitements sont nécessaires après une transplantation ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Immunosuppresseurs, suivi médical régulier et gestion des effets secondaires sont essentiels." } }, { "@type": "Question", "name": "Comment prévenir le rejet d'organe ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation d'immunosuppresseurs et un suivi régulier aident à prévenir le rejet." } }, { "@type": "Question", "name": "Quels sont les traitements pour les complications ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent nécessiter des médicaments, des interventions chirurgicales ou des soins intensifs." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires des médicaments ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier et des ajustements de dosage aident à gérer les effets secondaires." } }, { "@type": "Question", "name": "Quels sont les traitements pour les infections post-transplantation ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Antibiotiques et antiviraux sont souvent utilisés pour traiter les infections." } }, { "@type": "Question", "name": "Quelles sont les complications possibles après une transplantation ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Rejet, infections, complications vasculaires et problèmes de fonction de l'organe transplanté." } }, { "@type": "Question", "name": "Comment gérer le rejet aigu ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le rejet aigu nécessite souvent des ajustements de médicaments immunosuppresseurs." } }, { "@type": "Question", "name": "Quels sont les signes d'une infection grave ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, détérioration rapide de l'état général et symptômes respiratoires sévères." } }, { "@type": "Question", "name": "Quelles complications cardiovasculaires peuvent survenir ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les receveurs peuvent développer une hypertension, une athérosclérose ou des troubles du rythme." } }, { "@type": "Question", "name": "Comment prévenir les complications à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier, une bonne observance des traitements et un mode de vie sain sont cruciaux." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin de transplantation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Maladies chroniques, accidents, infections graves et cancers augmentent le besoin." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le don d'organes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé peut affecter la qualité des organes et la décision de don." } }, { "@type": "Question", "name": "Quels comportements augmentent les risques de maladies ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Tabagisme, alcoolisme, obésité et sédentarité augmentent les risques de maladies nécessitant un don." } }, { "@type": "Question", "name": "Comment les antécédents familiaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux de maladies héréditaires peuvent augmenter le risque de défaillance d'organe." } }, { "@type": "Question", "name": "Quels facteurs socio-économiques influencent le don ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'accès aux soins, l'éducation et la sensibilisation peuvent influencer les taux de don." } } ] } ] }

Sources (10000 au total)

Videoconference-Delivered Cognitive Behavioral Therapy for Parents of Adolescents With Internet Addiction: Pilot Randomized Controlled Trial.

The rise in internet addiction, including web-based gaming and social networking services, is a serious concern. Even with access to medical institutions and counseling services, individuals with inte... This study was a pilot randomized controlled trial to test the feasibility of remote cognitive behavioral therapy via videoconferencing for parents of adolescents with internet addiction.... A total of 13 parents of adolescents aged 12-20 years with internet addiction were recruited and randomly assigned to either 12 sessions of the videoconference-delivered cognitive behavioral therapy (... As the primary outcome, the mean total Internet Addiction Test score decreased from 67.7 (SD 18.3; 6/13, 46%) at week 0 to 56.2 (SD 25.1; 5/9, 56%) at week 13 in the vCBT group, compared to an increas... This study suggested the practical feasibility of vCBT for parents of adolescents with internet addiction. Further large-scale, multicenter randomized controlled trials are necessary to examine the ef... UMIN Clinical Trials Registry UMIN000032483; https://tinyurl.com/yuhen6c9....

The Statistical Fragility of Outcomes on Breast Reconstruction with Acellular Dermal Matrix: A Systematic Review of Randomized Controlled Trials.

Acellular dermal matrix (ADM) is pivotal in breast surgery, yet the statistical robustness of surgical outcomes remains underexplored. This study employs the fragility index (FI), reverse fragility in... Randomized controlled trials (RCTs) (2013-present) with dichotomous outcomes were sourced from PubMed, Embase, SCOPUS, Medline, and Cochrane databases. FI and rFI-event reversals needed to alter outco... Out of 33 studies screened, 19 RCTs comprising 204 outcomes were included, with a median FI of 4 (3 - 5) and FQ of 0.039 (0.029 - 0.070). Twenty-six outcomes achieved statistical significance, with a ... ADM-related breast reconstruction outcomes are statistically fragile, so reversal of a few outcomes or maintaining follow-up with patients may alter the significance of findings. Future researchers ar...

Efficiency assessment of intelligent patient-specific instrumentation in total knee arthroplasty: a prospective randomized controlled trial.

In total knee arthroplasty (TKA), the practical use of patient-specific instrumentation (PSI) has been reported previously with both advantage and disadvantage. The application of artificial intellige... 102 late-stage OA patients who met inclusive criteria were recruited in this prospective randomized controlled trial and separated into two groups (i-PSI vs. CI). In both groups, an AI preoperative pl... In resection outcomes, smaller deviation of lateral and medial distal femoral resection were found in i-PSI group than CI group (P = 0.032 and 0.035), while no difference was found in other resection ... Intelligent Patient-specific Instrumentation in TKA achieved simplified production flow than conventional PSI, while also showed more accurate resection, improved synthesis position and limb alignment...

Efficacy of Sternum Guard vs. bone wax in post-cardiac surgery patients: a randomized controlled trial.

Median sternotomy offers the main access during cardiac surgery. However, a surgical site infection (SSI) of the sternum is a distressing complication following this procedure. The incidence of postop... This single-blinded, single center randomized controlled trial comprised 414 adult patients who underwent cardiac surgery. The postoperative outcomes assessed were SSI and the quantity of blood lost f... The superficial SSI prevalence in the Sternum Guard group was lower than that in the bone wax group (2.9% vs. 8.2%, respectively; P=0.018). The incidence of deep SSI was also lower in the Sternum Guar... Sternum Guard (Vygon) had a significantly lower incidence of postoperative infection and bleeding from the sternum compared to bone wax....

Efficacy of Virtual Visitation in ICU During COVID-19 Pandemic: The ICU Visits Randomized Controlled Trial.

This study aimed to demonstrate the impact of virtual visits on the satisfaction of family members and the anxiety and depression of patients in the ICU during the COVID-19 pandemic.... A single-center, randomized controlled trial.... This study was conducted from July 2021 to May 2022, in the Seoul National University Hospital.... A total of 40 patients eligible for virtual visitation whose Richmond Agitation-Sedation Scale score was -2 or above were recruited and randomized into virtual visitation and usual care groups.... Virtual visitation began on the first day after ICU admission and continued until ICU discharge, lasting for a maximum of 7 days.... The primary outcome was the satisfaction level of the family members with care and decision-making in the ICU, assessed using the Family Satisfaction-ICU (FS-ICU) 24-survey questionnaire. Secondary ou... In the COVID-19 pandemic era, virtual visits to ICU patients helped reduce depression and anxiety levels of patients and increase the satisfaction of their family members. Enhancing access to virtual ...

Feasibility and effectiveness of cardiac telerehabilitation for older adults with coronary heart disease: A pilot randomized controlled trial.

Cardiac rehabilitation is a beneficial multidisciplinary treatment of exercise promotion, patient education, risk factor management, and psychosocial counseling for people with coronary heart disease ... The study randomized 43 older adults (84 % males) to the 12-week CTR intervention or standard of care. Guided by Social Cognitive Theory, participants received individualized in-person assessment and ... Participants in the CTR intervention group showed significant improvement in daily steps (T1: β = 4126.58, p = 0.001; T2: β = 5285, p = 0.01) and health-promoting lifestyle profile (T1: β = 23.26,... The CTR is feasible, safe and effective in improving physical activity and healthy behaviors in older adults with CHD. Considering the variation in individual cardiovascular risk factors, full-scale R...

Efficacy of the mHealth-Based Exercise Intervention re.flex for Patients With Knee Osteoarthritis: Pilot Randomized Controlled Trial.

Exercise therapy is recommended by international guidelines as a core treatment for patients with knee osteoarthritis. However, there is a significant gap between recommendations and practice in healt... This study aims to evaluate the efficacy of a 12-week fully automated app-based exercise intervention with and without a supporting knee brace on health-related outcomes, performance measures, and adh... This closed user group trial included participants with moderate to severe unicondylar painful knee osteoarthritis. Randomization was 1:1:2 into an intervention group (IG) with 2 subgroups (app-based ... A total of 61 participants were included (IG: n=30, 49%; CG: n=31, 51%; male: n=31, 51%; female: n=30, 49%; mean age 62.9, SD 8.5 years; mean BMI 27.7, SD 4.5 kg/m... Individuals with knee osteoarthritis undergoing a 12-week sensor-assisted app-based exercise intervention with or without an additional knee brace experienced clinically meaningful treatment effects r... German Clinical Trials Register (DRKS) DRKS00023269; https://drks.de/search/de/trial/DRKS00023269....